GlassScriptPhysician profile
Daniel J Karns
NPI 1174593099
$4,575.03
in general payments reported to CMS, 2019-2025
22 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,938 · 2020: $197 · 2021: $218 · 2022: $1,683 · 2023: $122 · 2024: $204 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,852.54 | 2019-2023 | Legion, Legion Revision, Journey II |
| Zimmer Biomet Holdings, INC. | $1,287.91 | 2019 | |
| Horizon Therapeutics Plc | $226.09 | 2019-2022 | |
| Stryker Corporation | $225.66 | 2023-2025 | Pangea, T2 Alpha, Cmi |
| Ferring Pharmaceuticals INC. | $158.45 | 2019-2023 | Euflexxa |
| Pacira Therapeutics, INC. | $156.83 | 2019-2020 | |
| Bioventus LLC | $150.71 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Rock Medical Orthopedics, INC. | $83.29 | 2019 | |
| Dynasplint Systems INC. | $72.40 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $45.56 | 2019-2024 | Camzyos |
| Amgen INC. | $39.37 | 2024-2025 | Krystexxa |
| Medline Industries LP | $38.73 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $35.61 | 2024 | Exparel, Zilretta |
| Vertex Pharmaceuticals Incorporated | $31.85 | 2024-2025 | |
| Arteriocyte Medical Systems, INC. | $29.46 | 2024 | Magellan |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carbofix Orthopedics INC | $28.03 | 2019 | |
| Vericel Corporation | $23.73 | 2023 | Maci |
| Gilead Sciences, INC. | $20.06 | 2023 | Veklury |
| Orthofix Medical, INC. | $19.92 | 2025 | Physio-Stim |
| Fidia Pharma USA INC. | $18.70 | 2019 | |
| Wright Medical Technology, INC. | $15.46 | 2019 | |
| Avanos Medical | $14.67 | 2024 | Trivisc Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Karns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.